Mehrdad Hasibi

415 total citations
38 papers, 273 citations indexed

About

Mehrdad Hasibi is a scholar working on Infectious Diseases, Epidemiology and Neurology. According to data from OpenAlex, Mehrdad Hasibi has authored 38 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 12 papers in Epidemiology and 7 papers in Neurology. Recurrent topics in Mehrdad Hasibi's work include COVID-19 Clinical Research Studies (10 papers), Long-Term Effects of COVID-19 (6 papers) and Antifungal resistance and susceptibility (5 papers). Mehrdad Hasibi is often cited by papers focused on COVID-19 Clinical Research Studies (10 papers), Long-Term Effects of COVID-19 (6 papers) and Antifungal resistance and susceptibility (5 papers). Mehrdad Hasibi collaborates with scholars based in Iran, United States and India. Mehrdad Hasibi's co-authors include Armin Rashidi, Nasrin Yazdani, SeyedAhmad SeyedAlinaghi, Seyed Amir Mirbagheri, Mehdi Abouzari, Sasan Dabiri, Fatemeh Ghadimi, Hassan Tavakoli, Marjan Asadollahi and Jalal Rezaii and has published in prestigious journals such as SHILAP Revista de lepidopterología, World Journal of Gastroenterology and Gastrointestinal Endoscopy.

In The Last Decade

Mehrdad Hasibi

34 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mehrdad Hasibi Iran 10 101 80 51 46 41 38 273
Ann M. Buchanan United States 10 118 1.2× 26 0.3× 16 0.3× 58 1.3× 12 0.3× 29 278
D Shmueli Israel 10 109 1.1× 61 0.8× 12 0.2× 150 3.3× 5 0.1× 36 336
Andreas Kyvernitakis United States 11 253 2.5× 75 0.9× 7 0.1× 261 5.7× 13 0.3× 37 513
Zaid Zoumot United Kingdom 13 52 0.5× 96 1.2× 30 0.6× 76 1.7× 11 0.3× 51 988
Maheen Z. Abidi United States 12 250 2.5× 43 0.5× 6 0.1× 237 5.2× 12 0.3× 31 404
Shimin Jasmine Chung Singapore 8 189 1.9× 49 0.6× 4 0.1× 145 3.2× 15 0.4× 45 412
Sowmya Nanjappa United States 10 69 0.7× 32 0.4× 5 0.1× 76 1.7× 12 0.3× 62 306
Kyeong‐Cheol Shin South Korea 13 39 0.4× 35 0.4× 12 0.2× 126 2.7× 4 0.1× 40 400
P.C. Wong China 16 162 1.6× 91 1.1× 3 0.1× 168 3.7× 18 0.4× 29 470
Donald R. Lazarus United States 12 89 0.9× 108 1.4× 22 0.4× 82 1.8× 4 0.1× 29 562

Countries citing papers authored by Mehrdad Hasibi

Since Specialization
Citations

This map shows the geographic impact of Mehrdad Hasibi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehrdad Hasibi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehrdad Hasibi more than expected).

Fields of papers citing papers by Mehrdad Hasibi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehrdad Hasibi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehrdad Hasibi. The network helps show where Mehrdad Hasibi may publish in the future.

Co-authorship network of co-authors of Mehrdad Hasibi

This figure shows the co-authorship network connecting the top 25 collaborators of Mehrdad Hasibi. A scholar is included among the top collaborators of Mehrdad Hasibi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehrdad Hasibi. Mehrdad Hasibi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Badali, Hamid, Shahram Mahmoudi, Shayan Amiri, et al.. (2025). Ten-Year Experience on 601 Patients with Mucormycosis at Eight Tertiary Care Centers in Iran. Mycopathologia. 190(5). 87–87.
2.
Dabiri, Sasan, et al.. (2022). Predictive factors in treatment response of malignant external otitis. European Archives of Oto-Rhino-Laryngology. 280(1). 159–166. 3 indexed citations
3.
Hasibi, Mehrdad, et al.. (2022). The Value of Spiral Chest Computed Tomography Scan in the Diagnosis of Asymptomatic Coronavirus Carriers among Paranasal Sinus and Pharynx Surgery Candidates. International Archives of Otorhinolaryngology. 26(3). e487–e490. 1 indexed citations
4.
Tavakolpour, Soheil, et al.. (2022). Risk Factors of COVID-19 Associated Mucormycosis (CAM) in Iranian Patients: A Single-Center Retrospective Study. Mycopathologia. 187(5-6). 469–479. 8 indexed citations
5.
Hasibi, Mehrdad, et al.. (2022). Convalescent plasma therapy in patients with severe COVID-19, A single-arm, retrospective study. Microbial Pathogenesis. 165. 105482–105482. 1 indexed citations
6.
Nowroozi, Ali, et al.. (2021). COVID-19 and Alcohol Misuse: A Case Report. Infectious Disorders - Drug Targets. 21(8). e160921191123–e160921191123. 1 indexed citations
7.
Dabiri, Sasan, et al.. (2020). Facial nerve paralysis in malignant otitis externa: comparison of the clinical and paraclinical findings. Acta Oto-Laryngologica. 140(12). 1056–1060. 17 indexed citations
8.
Afhami, Shirin, et al.. (2018). Assessment of device-associated infection rates in teaching hospitals in Islamic Republic of Iran. Eastern Mediterranean Health Journal. 25(2). 90–97. 13 indexed citations
9.
Hasibi, Mehrdad, et al.. (2017). Pancreatic Tuberculosis in an Immunocompetent Patient: A Case Report and Review of the Literature. Middle East Journal of Digestive Diseases. 9(4). 239–241. 5 indexed citations
10.
Hasibi, Mehrdad, Sirous Jafari, Seyed Ali Dehghan Manshadi, et al.. (2017). Efficacy of Intralipid Infusion in Reducing Amphotericin-B–associated Nephrotoxicity in Head and Neck Invasive Fungal Infection: A Randomized, Controlled Trial. Ear Nose & Throat Journal. 96(2). E18–E22. 5 indexed citations
11.
Hasibi, Mehrdad, et al.. (2012). A Misdiagnosis Led to an Extensive Skull Base Surgery: Infratemporal Tuberculosis Mimicking Giant Cell Tumor. Indian Journal of Otolaryngology and Head & Neck Surgery. 65(1). 83–85. 2 indexed citations
12.
Mokhtari, Zahra, et al.. (2011). Evaluation of Safety Standards in Operating Rooms of Tehran University of Medical Sciences (TUMS) Hospitals in 2010. SHILAP Revista de lepidopterología. 5 indexed citations
13.
Dargahi, Hossein, et al.. (2011). Evaluation of safety standards in operating rooms of Tehran University of Medical Sciences (TUMS) Hospitals in 2010. 5(2). 10–17. 7 indexed citations
14.
Hasibi, Mehrdad, et al.. (2011). Drug-induced complications of anti-tuberculosis drugs in HIV patients. 68(10). 611–616. 2 indexed citations
15.
Esfandiari, Khalil, et al.. (2009). Evaluation of mupirocin ointment in control of central venous catheter related infections: a randomized clinical trial. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Hasibi, Mehrdad, et al.. (2008). MORTALITY RATE OF INFECTIOUS DISEASE IN RELATION TO HOLIDAYS: THREE YEAR STUDY IN IMAM KHOMEINI HOSPITAL. 65(10). 50–54. 2 indexed citations
17.
Hasibi, Mehrdad, et al.. (2008). Epidemiological, Clinical, Laboratory Findings, and Outcomes of Disseminated Tuberculosis in Tehran, Iran. Southern Medical Journal. 101(9). 910–913. 13 indexed citations
18.
Hasibi, Mehrdad, et al.. (2008). Auricular leishmaniasis mimicking squamous cell carcinoma. The Journal of Laryngology & Otology. 123(8). 915–918. 12 indexed citations
19.
Mahmoodi, Mojtaba, et al.. (2008). Poor Physical Activity in the Elderly as Assessed by a Visual Analogue Scale is Associated with Dyslipidemia. Pakistan Journal of Biological Sciences. 11(19). 2367–2369. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ann M. Buchanan Breakdown of academic impact, for papers by D Shmueli Breakdown of academic impact, for papers by Andreas Kyvernitakis Breakdown of academic impact, for papers by Zaid Zoumot Breakdown of academic impact, for papers by Maheen Z. Abidi Breakdown of academic impact, for papers by Shimin Jasmine Chung Breakdown of academic impact, for papers by Sowmya Nanjappa Breakdown of academic impact, for papers by Kyeong‐Cheol Shin Breakdown of academic impact, for papers by P.C. Wong Breakdown of academic impact, for papers by Donald R. Lazarus
Rankless by CCL
2026